Mark Reynolds

City:

Millbrae, California

Country:

United States

Published Applications:

Last publication date:

2025-03-27

Top Assignees for applications by Mark Reynolds

The entities that hold a legal rights for patent applications filed by inventor Reynolds Mark:

Genentech, Inc. 2 South San Francisco, CA United States
Loxo Oncology, Inc. 2 Stamford, CT United States
Exelixis, Inc. 1 Alameda, CA United States
Loxo Oncology, Inc. 1 Stanford, CT United States

Recent patent applications by Reynolds Mark

Mark Reynolds from Millbrae, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-03-27

US20250099604A1

Human necessities

PHARMACEUTICAL COMPOSITIONS COMPRISING ANTI-TISSUE FACTOR ANTIBODY-DRUG CONJUGATES

#2 | 2022-06-30

US20220202788A1

Human necessities

Formulations of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile

#3 | 2022-03-24

US20220087988A1

Human necessities

Formulations of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile

#4 | 2021-03-18

US20210077474A1

Human necessities

Formulations of 6-(2-hydroxy-methylpropoxy-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile

#5 | 2012-02-23

US20120045448A1

Chemistry; metallurgy

TRP-P8 ACTIVE COMPOUNDS AND THERAPEUTIC TREATMENT METHODS

#6 | 2005-09-15

US20050203135A1

Human necessities

Antagonists for treatment of CD/11CD18 adhesion receptor mediated disorders

#7 | 2005-04-28

US20050090514A1

Chemistry; metallurgy

Trp-p8 active compounds and therapeutic treatment methods

InventorID:

3104387 ⎘